The Role of Sales in Sales Enablement

However, with a regular commute time that consumes a couple of hours each day, I have shifted my focus to podcasts and audiobooks. One of my favorite podcasts is the Inside Sales Enablement series by Scott Santucci and Brian Lambert. In their last episode, they spent time reviewing their thoughts and insights from the Sales Enablement Soiree that recently took place in Boston. They spoke to the fact that there is a great deal of confusion and misalignment amongst practitioners, in part because of uncertainty about where sales enablement begins and ends.

Spotlight

Digital Health Canada

Digital Health Canada connects, inspires, and educates the digital health professionals creating the future of health in Canada. Our members are a diverse community of accomplished, influential professionals working to make a difference in advancing healthcare through information technology. Digital Health Canada fosters network growth and connection; brings together ideas from multiple segments for incubation and advocacy; supports members through professional development at the individual and organizational level; and advocates for the Canadian digital health industry.

OTHER ARTICLES
MedTech

Better Purification and Recovery in Bioprocessing

Article | July 11, 2022

In the downstream portion of any bioprocess, one must pick through the dross before one can seize the gold the biotherapeutic that the bioprocess was always meant to generate. Unfortunately, the dross is both voluminous and various. And the biotherapeutic gold, unlike real gold, is corruptible. That is, it can suffer structural damage and activity loss. When discarding the dross and collecting the gold, bioprocessors must be efficient and gentle. They must, to the extent possible, eliminate contaminants and organic debris while ensuring that biotherapeutics avoid aggregation-inducing stresses and retain their integrity during purification and recovery. Anything less compromises purity and reduces yield. To purify and recover biotherapeutics efficiently and gently, bioprocessors must avail themselves of the most appropriate tools and techniques. Here, we talk with several experts about which tools and techniques can help bioprocessors overcome persistent challenges. Some of these experts also touch on new approaches that can help bioprocessors address emerging challenges.

Read More
MedTech

How to Choose a Reliable Biotech Clinical Trial Management System?

Article | October 7, 2022

Introduction The medical and life-science industries are experiencing a robust transformation with the increasing prevalence of various types of diseases, including infectious diseases, chronic disorders, and acute conditions around the world. As a result, a significant rise in demand for more effective therapeutic drugs and bionics is being witnessed, leading to a swift increase in the number of clinical trials. For a successful trial, it is important for biotech companies to ensure the data submitted to regulatory bodies regarding clinical trials is accurate, reliable, and definitive from an ethical point of view. A reliable clinical trial management system plays a vital role in collecting, monitoring, and managing clinical data. The availability of high-quality clinical data also helps clinical research institutions make efficient treatment decisions and provide proper patient care. Hence, a number of biotech companies and research organizations are focusing on leveraging innovative clinical trial management solutions to handle a large amount of data, particularly in multi-center trials, and generate reliable, high-quality, and statistically sound data from clinical trials. However, selecting the most appropriate and reliable clinical trial management system is vital for the clinical trial's success. Let's see some of the steps that will assist these firms in choosing the right CTMS. Key Steps for Selecting Right Biotech Clinical Trial Management System Prioritize Study Needs Considering and prioritizing study needs is a crucial step in choosing the most reliable clinical trial management system for biotech companies. Prioritizing helps them to identify a solution that improves the study's quality and removes uncertainty for researchers when faced with difficult choices. Hence, biotech and life-science organizations should choose a clinical trial system that is simple to use, well-organized, and suitably designed to minimize the number of clicks required to complete a task. Select CTMS with Multiple Integrations Integrated clinical trial management systems provide the best value for the companies’ funds as they guarantee the smooth functioning of research protocols. In addition, integrations are necessary to fully understand the importance and advantages of clinical trial management software for ensuring smooth transitions between site management and data collection. Biotech and clinical research should look for CTMS platforms that can integrate with electronic medical record (EMR) platforms and clinical research process content (CRPC) billing grids. This will allow them to use the same billing designations and ensure compliance while minimizing the need for duplicate processes. Ensure System Compliance and Security Clinical research organizations need to adhere to a plethora of complex regulations in order to ensure compliance with one of the most challenging environments of principles, which is information security and privacy. Security and system compliance are vital aspects of choosing the right CTMS solutions for biotech firms as they assist in building trust and form a part of the system’s duties. While selecting CTMS systems, it is essential for companies engaged in clinical research to ensure that these platforms are able to configure both, group and individual permissions, along with having a data backup and recovery plan for hosted systems. This will allow companies to assess the privacy and security implications of research and anticipate complications that may arise in each phase of the project. Assess the Scalability Choosing a scalable CTMS that can accommodate various types of fluctuations and expansions enables biotech and clinical firms to quickly adapt to fast-changing trends and demand spikes while reducing maintenance costs and enhancing user agility. As scalability also means secure and expanded data storage, these businesses should instead use SaaS solutions than manually manage an ever-growing collection of hard drives. The right CTMS ensures accommodating the firm’s availability requirements without incurring the capital costs associated with expanding a physical infrastructure. The Closing Thought A well-executed and successful clinical trial involves multiple stages and processes. Several quality controls and stringent adherence to regulations are essential for the steps, along with efficient cross-departmental processes and procedures. Incorporating the right CTMS paves the way for paperless data collection, regulatory filing, and fiscal management tools for biotech researchers and administrative personnel.

Read More
MedTech

AI and Biotechnology: The Future of Healthcare Industry

Article | July 16, 2022

Artificial intelligence has grasped the foundation in biotech. It can have the most innovative impact on biotechnology. AI has already established its presence in our day-to-day life. AI has made the existence of self-driving cars possible. Likewise, the benefits and quality that it can contribute to biotech can also be felt. With AI, bio technicians will be able to enhance virtual screening, overlook preliminary datasets from clinics, and decipher an enormous amount of information. It can also help in improving the medication process by gathering and analyzing every bit of information. The Significance of AI in Biotechnology In the past few years, the application of artificial intelligence in the biotechnology industry has shifted from being sci-fi to sci-fact. A vast number of biotech companies like Deep Genomics are adopting AI for making data-driven decisions and use analytics tools to work efficiently. Unlike the AI robots in sci-fi that are ready to take over the world. AI designed for biotech has been designed to solve certain problems or complete a bunch of tasks by using automated algorithms. The aim of AI technology for biotech is to collect insights along with hidden patterns from large amounts of data. All the different industries of biotech including agriculture, animal, medical, industrial, and bioinformatics are gradually being affected by artificial intelligence. Moreover, the biotech industry is realizing that AI enables them some of the important strength to their business, including: Expanding accessibility Cost-effectiveness Critical predictions Efficient decision-making Research centers like PwC have also estimated output of $15.7 trillion by 2030 solely with AI contribution in industries. A survey revealed that about 44% of life science experts are using AI for R&D activities, as well. Use of AI in Biotechnology Altering Biomedical and Clinical Data So far the most developed use of AI is its ability to read voluminous data records and interpret them. It can prove to be a life-save for bio technicians who would have to examine that much data from research publications by themselves for the validation of their hypothesis. With the help of AI, clinical studies of patients will also become easier as all the examination reports and prescriptions will be stored in one place for cross-reference. Furthermore, it will also help in blending and fetching data into usable formats for analysis. Test Result Prediction Through trial and error, AI along with machine learning can help in predicting the response of the patient to certain drugs to provide more effective outcomes. Drug Design & Discovery AI plays a vital role whether it’s designing a new molecule or identifying new biological targets. It helps in identifying and validating drugs. It reduces the cost and time spent on the entire drug trial process and reaches the market. Personalized Medications for Rare Diseases With the combination of body scan results, patients’ body and analytics, AI can also help in detecting dangerous diseases at an early stage. Improving Process of Manufacturing To improve the process of manufacturing in biotechnology, AI offers a wide range of opportunities. It controls quality, reduces wastage, improves useability, and minimizes the designing time. Moving Towards AI-Enhanced Biotech Future Ever since the concept of artificial intelligence has arrived, being curious by nature, humans have started working towards achieving this goal. It has been growing at a fast pace while showing unbelievable growth and achievements at times. In comparison to the traditional methods used in the biotechnology industry, AI-based methods seem more reliable and accurate. In the upcoming years, it will show its success by improving the quality of health people have. You can also develop your AI-based application or know more about it by taking IT consultations.

Read More
MedTech

Expansion of BioPharma: Opportunities and Investments

Article | July 12, 2022

Biopharmaceutical innovations are among the most ingenious and refined achievements of modern medical science. New concepts, techniques, and therapies are emerging, such as the cell therapy Provenge, which can be used to treat cancer, and gene therapies, which provide even more amazing promises of disease remission and regenerative medicine. In addition, the COVID-19 pandemic has caused a huge boom in the pharmaceutical industry. This is because more and more attention is being paid to increasing manufacturing capacity and starting new research on drug development. Biopharma: Leading the Way in the Pharma Sector In the past couple of years, the biopharmaceutical sector has deepened its roots across the medical and pharmaceutical industries, on account of the transformation of pharmaceutical companies towards biotechnology, creating opportunities for growth. Also, growing advancements in technologies such as 3D bioprinting, biosensors, and gene editing, along with the integration of advanced artificial intelligence and virtual and augmented reality are estimated to further create prospects for growth. According to a study, the biopharmaceutical sector makes nearly $163 billion around the world and grows by more than 8% each year, which is twice as fast as the traditional pharma sector. Massive Investments Directed Towards Biopharma Investing in biotech research and development (R&D) has yielded better returns than the pharma industry average. Hence, a number of pharmaceutical companies are shifting their presence toward biopharma to capitalize on the upcoming opportunities by investing in and expanding their biotechnology infrastructure. For instance, Thermo Fisher Scientific Inc., an American manufacturer of scientific instrumentation, reagents and consumables, and software services, announced an investment of $97 million to expand its bioanalytical laboratory operations into three new locations in the U.S. With this investment, the company will add 150,000 square feet of scientific workspace and install the most advanced drug development technologies to produce life-changing medicines for patients in need.

Read More

Spotlight

Digital Health Canada

Digital Health Canada connects, inspires, and educates the digital health professionals creating the future of health in Canada. Our members are a diverse community of accomplished, influential professionals working to make a difference in advancing healthcare through information technology. Digital Health Canada fosters network growth and connection; brings together ideas from multiple segments for incubation and advocacy; supports members through professional development at the individual and organizational level; and advocates for the Canadian digital health industry.

Related News

BIGTINCAN EXPANDS TECH MARKET PRESENCES WITH ACQUISITION OF VEELO INC.

Bigtincan | July 25, 2019

Bigtincan (ASX:BTH), the leader in mobile, AI-powered sales enablement automation, today announced the acquisition of Veelo Inc., a pioneer in sales enablement, to expand Bigtincan’s presence and offerings in the technology market vertical. The combination of Bigtincan’s solution, designed with the mobile-first user in mind, and Veelo’s focus on traditional sales enablement with key enhancements for desktop and web solutions, will augment and compliment the different ways sales teams work, no matter which platform they choose. Veelo’s award-winning sales enablement platform increases sales performance by predicatively guiding sellers on what to know, say and do. Designed with brain science principles in mind, the Veelo Vault ready-made sales enablement templates showcase the most relevant resources available to each sales person. Veelo’s intelligent search also provides instant access for teams to quickly find relevant images, videos, blog posts and documents. Bigtincan will integrate the Veelo Sales Enablement Platform with the Bigtincan platform to provide additional capabilities to sales teams, including the creation of a single pane of reference for users to manage content and training materials, and automatically deliver them to user devices.

Read More

BIGTINCAN RECOGNIZED BY KEY INDUSTRY ORGANIZATIONS AS LEADER IN SALES ENABLEMENT

Bigtincan | August 13, 2019

Bigtincan (ASX:BTH), the leader in mobile, AI-powered sales enablement automation, was presented with the MarTech Breakthrough Award for “Best Sales Enablement Software for SMBs” for the second year in a row. Additionally Bigtincan was recently named a “Sales Automation Solution” Gold Winner, “Cloud Computing/SaaS Product or Service for Sales” Bronze Winner and “Best New Product or Service for Sales” Gold Winner by the Customer Sales and Service World Awards. This follows a recognition from Selling Power as a Top 10 AI Solutions for Sales in 2019. Bigtincan was also recently shortlisted for Best Application of AI for Sales and Marketing for the AIconics Awards. The MarTech Breakthrough Awards, Customer Sales and Service World Awards, Selling Power Top 10 Solutions list and AIconics Awards all recognize achievements in key areas of sales enablement – martech, customer service and sales – and acknowledge organizations who set industry benchmarks for excellence by addressing some of the biggest challenges sales teams and marketers face. Bigtincan continues to enhance its advanced, AI-powered platform with AR and VR pitch building offerings and new voice assistant capabilities through the Bigtincan Genie to answer questions on-the-go. Furthermore, these new capabilities allow sales teams to customize and combine documents to build decks that can easily be presented via iPad or shared with others, as well as presented with AR, VR and enhanced multi-media content.

Read More

BIGTINCAN NAMED IN GARTNER’S MARKET GUIDE FOR SALES ENGAGEMENT PLATFORMS, MEETING ALL IDENTIFIED CAPABILITIES

Bigtincan | August 27, 2019

Bigtincan (ASX:BTH), the leader in mobile, AI-powered sales enablement automation, today announced it has been recognized as a Representative Vendor of Sales Engagement Platforms in all of the capabilities defined by Gartner as part of the August 2019 Market Guide for Sales Enablement Platforms* for the second consecutive year. According to the report, “sales engagement platforms expand sales enablement capabilities by using information about buyer and seller engagement to deliver better sales results. Application leaders supporting sales technology should use this Market Guide to understand the key capabilities of 14 vendors.“We are honored to once again be recognized by Gartner as a Representative Vendor in their 2019 Market Guide for Sales Enablement Platforms,” said David Keane, Bigtincan co-founder and CEO. “We believe Gartner’s recognition further validates Bigtincan’s leadership in this growing and evolving market. Bigtincan continues to make strategic acquisitions to expand into new verticals while adding capabilities to replace outdated systems with intelligent tools of the future. Our products help sales teams learn faster, sell smart and be more productive on a global scale.”

Read More

BIGTINCAN EXPANDS TECH MARKET PRESENCES WITH ACQUISITION OF VEELO INC.

Bigtincan | July 25, 2019

Bigtincan (ASX:BTH), the leader in mobile, AI-powered sales enablement automation, today announced the acquisition of Veelo Inc., a pioneer in sales enablement, to expand Bigtincan’s presence and offerings in the technology market vertical. The combination of Bigtincan’s solution, designed with the mobile-first user in mind, and Veelo’s focus on traditional sales enablement with key enhancements for desktop and web solutions, will augment and compliment the different ways sales teams work, no matter which platform they choose. Veelo’s award-winning sales enablement platform increases sales performance by predicatively guiding sellers on what to know, say and do. Designed with brain science principles in mind, the Veelo Vault ready-made sales enablement templates showcase the most relevant resources available to each sales person. Veelo’s intelligent search also provides instant access for teams to quickly find relevant images, videos, blog posts and documents. Bigtincan will integrate the Veelo Sales Enablement Platform with the Bigtincan platform to provide additional capabilities to sales teams, including the creation of a single pane of reference for users to manage content and training materials, and automatically deliver them to user devices.

Read More

BIGTINCAN RECOGNIZED BY KEY INDUSTRY ORGANIZATIONS AS LEADER IN SALES ENABLEMENT

Bigtincan | August 13, 2019

Bigtincan (ASX:BTH), the leader in mobile, AI-powered sales enablement automation, was presented with the MarTech Breakthrough Award for “Best Sales Enablement Software for SMBs” for the second year in a row. Additionally Bigtincan was recently named a “Sales Automation Solution” Gold Winner, “Cloud Computing/SaaS Product or Service for Sales” Bronze Winner and “Best New Product or Service for Sales” Gold Winner by the Customer Sales and Service World Awards. This follows a recognition from Selling Power as a Top 10 AI Solutions for Sales in 2019. Bigtincan was also recently shortlisted for Best Application of AI for Sales and Marketing for the AIconics Awards. The MarTech Breakthrough Awards, Customer Sales and Service World Awards, Selling Power Top 10 Solutions list and AIconics Awards all recognize achievements in key areas of sales enablement – martech, customer service and sales – and acknowledge organizations who set industry benchmarks for excellence by addressing some of the biggest challenges sales teams and marketers face. Bigtincan continues to enhance its advanced, AI-powered platform with AR and VR pitch building offerings and new voice assistant capabilities through the Bigtincan Genie to answer questions on-the-go. Furthermore, these new capabilities allow sales teams to customize and combine documents to build decks that can easily be presented via iPad or shared with others, as well as presented with AR, VR and enhanced multi-media content.

Read More

BIGTINCAN NAMED IN GARTNER’S MARKET GUIDE FOR SALES ENGAGEMENT PLATFORMS, MEETING ALL IDENTIFIED CAPABILITIES

Bigtincan | August 27, 2019

Bigtincan (ASX:BTH), the leader in mobile, AI-powered sales enablement automation, today announced it has been recognized as a Representative Vendor of Sales Engagement Platforms in all of the capabilities defined by Gartner as part of the August 2019 Market Guide for Sales Enablement Platforms* for the second consecutive year. According to the report, “sales engagement platforms expand sales enablement capabilities by using information about buyer and seller engagement to deliver better sales results. Application leaders supporting sales technology should use this Market Guide to understand the key capabilities of 14 vendors.“We are honored to once again be recognized by Gartner as a Representative Vendor in their 2019 Market Guide for Sales Enablement Platforms,” said David Keane, Bigtincan co-founder and CEO. “We believe Gartner’s recognition further validates Bigtincan’s leadership in this growing and evolving market. Bigtincan continues to make strategic acquisitions to expand into new verticals while adding capabilities to replace outdated systems with intelligent tools of the future. Our products help sales teams learn faster, sell smart and be more productive on a global scale.”

Read More

Events